Chemiluminescent-based VWF Assay Panel
The fully automated HemosIL AcuStar VWF assay panel, designed exclusively for use on the ACL AcuStar® Hemostasis Testing System, includes HemosIL AcuStar VWF Antigen (VWF:Ag) and HemosIL AcuStar VWF Ristocetin Cofactor (VWF:RCo) Activity assays. This new panel automates and simplifies laboratory testing for von Willebrand disease (VWD), a key part of clinical investigation. Moreover, HemosIL AcuStar VWF:RCo is the first fully automated, chemiluminescent assay to use recombinant technology, allowing full automation and greater precision than platelet-based tests. It meets guidelines on VWD investigation and enhances accuracy versus manual methods. Additionally, chemiluminescence offers an enhanced linearity range to quantify extremely low levels of VWF concentrations. Like all reagents on the ACL AcuStar System, HemosIL AcuStar VWF assays are ready-to-use, cartridge-based and offer results in 30 minutes—on-demand, 24/7. This is the third specialty assay panel commercialized on the ACL AcuStar system and it is currently distributed in the EU and other international territories as a CE IVD Mark product
Supplier: Instrumentation Lab. Inc.
Website:
